Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.33 |
| ▸ | CSF3R | Q99062 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16169701 | 0.94 | CSF3R (0.36) | PIM1PIM2CSF3R | |
| SCHEMBL16169705 | 0.92 | F9 (0.32) | — | |
| SCHEMBL16169694 | 0.90 | F9 (0.34) | PIM1PIM2CSF3R | |
| SCHEMBL16172090 | 0.87 | F9 (0.33) | — | |
| SCHEMBL15805867 | 0.84 | F9 (0.36) | — | |
| SCHEMBL15805960 | 0.83 | PIM1 (0.39) | PIM1PIM2CSF3R | |
| SCHEMBL16169699 | 0.81 | PIM1 (0.40) | PIM1PIM2CSF3R | |
| SCHEMBL15805864 | 0.76 | PIM1 (0.43) | PIM1PIM2CSF3R | |
| SCHEMBL16169700 | 0.75 | PIM1 (0.39) | PIM1PIM2 | |
| SCHEMBL16419736 | 0.75 | L3MBTL1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | CELLCEUTIX CORPORATION (US) | 2014-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | ALG1, CD44, MUC1 | PIM1 1725/4885PIM2 2729/4885CSF3R 1989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.